Jason Lettmann
University of Iowa
Tell me more about Jason Lettmann?
Jason Lettmann is a highly experienced professional with 26.6 years of work experience in venture capital, strategy, start-ups, mergers and acquisitions, and corporate development. He is currently a Principal at Morgenthaler, specializing in the life science and medical device sectors. Prior to joining Morgenthaler, he held various positions at Split Rock Partners, including Vice President at Split Rock Partners and Vice President at Tarsus Medical. Jason also has extensive experience in early-stage venture investments in the medical devices and life sciences. He has worked with renowned companies like Guidant Corporation's Compass Group and has a strong background in genetic research.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Jason Lettmann joined Morgenthaler in 2009 and is a Principal on the Life Science Team. Jason is based in Palo Alto, CA, and invests in the life science and medical device sectors. He serves on the Board of Relievant Medsystems, Second Genome and Vapotherm, is a co-founder and on the Board of Tarsus Medical, and is a Board observer at Ardian (acquired by Medtronic), Cabochon Aesthetics, The Foundry and Moximed. Before joining Morgenthaler, Jason was a Vice President at Split Rock Partners where he focused on early-stage venture investments in medical devices and the life sciences. During his time at Split Rock, Jason was actively involved with the founding of Zyga Technologies as well as with several start-ups founded at ForSight Labs and the Foundry incubators. He also was involved with the firm’s investments in Evalve (acquired by Abbott Labs), Entellus Medical, EBR Systems, Mirabilis and Miramar Labs. Prior to Split Rock, Jason’s experience includes tenure with Guidant Corporation’s Compass Group which focused on corporate venture and business development as well as a consultant with Accenture’s Health and Life Science practice where he advised clients across the medical device, pharmaceutical and health payer sectors. Jason also previously worked as a genetic research analyst at the University of Iowa Hospitals and Clinics.
...See MoreWork Experience
ceo alx oncology
Board Member
Biotechnology Research
Jason Lettmann's Professional Milestones
- Vice President (2006-06-01~2009-06-01): Driving strategic decision-making and fostering a positive stakeholder experience for the company.
- Consultant (2000-01-01~2004-01-01): Implementing data-driven strategies to optimize business performance and drive strategic decision-making.
Education
Pre-medicine/ Psychology,
Ba
788918400-915148800Skill
Venture Capital
Strategy
Start Ups
Mergers And Acquisitions
Corporate Development
Business Strategy
Private Equity
Financial Modeling
Entrepreneurship
Due Diligence
Investment Banking
Valuation
Investments
Strategic Partnerships
Corporate Finance
Emerging Markets
Mergers
Lbo
Small Engine Repair
Certification
Colleagues
Nathan Caffo
Chief Business Officer
Sophia Randolph MD PhD
chief medical officer at alx oncology
Shelly Pinto
Vice President | Finance | Chief Accounting Officer
Jaume Pons
president and ceo at alx oncology
Shelly Wong-Pinto, CPA
vp finance & chief accounting officer at alx oncology
Other Named Jason Lettmann
Frequently asked questions
We found 16 Jason Lettmann's email addresses
We found 3 Jason Lettmann's phone numbers
Jason Lettmann's social media include: Linkedin,
Jason Lettmann works for ALX Oncology
Jason Lettmann's role in ALX Oncology is ceo alx oncology
Jason Lettmann works in the industry of Biotechnology Research
Jason Lettmann's colleagues are Nathan Caffo,Sophia Randolph MD PhD,Shelly Pinto
Jason Lettmann's latest job experience is ceo alx oncology at ALX Oncology
Jason Lettmann's latest education in University of Iowa